Triple-Negative Breast Cancer: Risk Factors to Potential TargetsBryan P. Schneider, Lisa A. Carey, Eric P. Winer et al.|Clinical Cancer Research|2008Cited by 456
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT StudyElizabeth Bancroft, Apollonia T. Helderman-van den Enden, Elizabeth Page et al.|European Urology|2014Cited by 250
<i>PALB2</i>, <i>CHEK2</i> and <i>ATM</i> rare variants and cancer risk: data from COGSMelissa C. Southey, Zhi L. Teo, Paolo Radice et al.|Journal of Medical Genetics|2016Cited by 217
Clinical practice guidelines for BRCA1 and BRCA2 genetic testingPascal Pujol, Julie A. Vendrell, Massimo Barberis et al.|European Journal of Cancer|2021Cited by 174
Identification of a novel truncating PALB2mutation and analysis of its contribution to early-onset breast cancer in French-Canadian womenWilliam D. Foulkes, Steven A. Narod|Breast Cancer Research|2007Cited by 159